Cargando…

Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar

BACKGROUND: With an increasingly strained health system budgets, healthcare services need to continually demonstrate evidence of economic benefits. This study sought to evaluate the economic impact of interventions initiated by clinical pharmacists in an adult general tertiary hospital. METHODS: A r...

Descripción completa

Detalles Bibliográficos
Autores principales: Abushanab, Dina, Atchan, Mounir, Elajez, Reem, Elshafei, Mohamed, Abdelbari, Ahmed, Al Hail, Moza, Abdulrouf, Palli Valapila, El-Kassem, Wessam, Ademi, Zanfina, Fadul, Abdalla, Abdalla, Elmustafa, Diab, Mohammad Issam, Al-Badriyeh, Daoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234553/
https://www.ncbi.nlm.nih.gov/pubmed/37262042
http://dx.doi.org/10.1371/journal.pone.0286419
_version_ 1785052517094129664
author Abushanab, Dina
Atchan, Mounir
Elajez, Reem
Elshafei, Mohamed
Abdelbari, Ahmed
Al Hail, Moza
Abdulrouf, Palli Valapila
El-Kassem, Wessam
Ademi, Zanfina
Fadul, Abdalla
Abdalla, Elmustafa
Diab, Mohammad Issam
Al-Badriyeh, Daoud
author_facet Abushanab, Dina
Atchan, Mounir
Elajez, Reem
Elshafei, Mohamed
Abdelbari, Ahmed
Al Hail, Moza
Abdulrouf, Palli Valapila
El-Kassem, Wessam
Ademi, Zanfina
Fadul, Abdalla
Abdalla, Elmustafa
Diab, Mohammad Issam
Al-Badriyeh, Daoud
author_sort Abushanab, Dina
collection PubMed
description BACKGROUND: With an increasingly strained health system budgets, healthcare services need to continually demonstrate evidence of economic benefits. This study sought to evaluate the economic impact of interventions initiated by clinical pharmacists in an adult general tertiary hospital. METHODS: A retrospective review of clinical pharmacist interventions was carried out throughout follow-up durations in March 2018, July/August 2018, and January 2019 in Hamad General Hospital (HGH) at Hamad Medical Corporation (HMC) in Qatar. The study included clinical pharmacy interventions data of patients admitted to the internal medicine, critical care, and emergency wards. Included interventions were documented by clinical pharmacists or clinical pharmacy specialists, and approved by physicians. Interventions by non-clinical pharmacists or with missing data were excluded. Adopting the perspective of HMC, we calculated the total economic benefit, which is the sum of the cost savings and the cost avoidance associated with the interventions. Cost savings was defined as the reduced cost of therapy associated with therapy changes minus the cost of intervention and cost avoidance was the cost avoided by eliminating the occurrence of adverse drug events (ADEs). Sensitivity analyses were performed to assess the robustness of results against uncertainties. RESULTS: A total of 852 interventions, based on 340 patients, were included. The analysis projected an annual total benefit of QAR 2,267,036 (USD 621,106) based on a negative cost-savings of QAR-175,139 (USD-47,983) and a positive cost avoidance of QAR741,898 (USD203,260) over the 3-month follow-up period. The uncertainty analysis demonstrated the robustness of outcomes, including a 100% probability of positive economic benefit. CONCLUSIONS: The clinical pharmacist intervention was associated with an increased cost of resource use, which was overtaken by the cost avoidance generated. The pharmacy intervention, therefore, is an overall economically beneficial practice in HGH, reducing ADEs with considerable consequential positive economic savings.
format Online
Article
Text
id pubmed-10234553
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-102345532023-06-02 Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar Abushanab, Dina Atchan, Mounir Elajez, Reem Elshafei, Mohamed Abdelbari, Ahmed Al Hail, Moza Abdulrouf, Palli Valapila El-Kassem, Wessam Ademi, Zanfina Fadul, Abdalla Abdalla, Elmustafa Diab, Mohammad Issam Al-Badriyeh, Daoud PLoS One Research Article BACKGROUND: With an increasingly strained health system budgets, healthcare services need to continually demonstrate evidence of economic benefits. This study sought to evaluate the economic impact of interventions initiated by clinical pharmacists in an adult general tertiary hospital. METHODS: A retrospective review of clinical pharmacist interventions was carried out throughout follow-up durations in March 2018, July/August 2018, and January 2019 in Hamad General Hospital (HGH) at Hamad Medical Corporation (HMC) in Qatar. The study included clinical pharmacy interventions data of patients admitted to the internal medicine, critical care, and emergency wards. Included interventions were documented by clinical pharmacists or clinical pharmacy specialists, and approved by physicians. Interventions by non-clinical pharmacists or with missing data were excluded. Adopting the perspective of HMC, we calculated the total economic benefit, which is the sum of the cost savings and the cost avoidance associated with the interventions. Cost savings was defined as the reduced cost of therapy associated with therapy changes minus the cost of intervention and cost avoidance was the cost avoided by eliminating the occurrence of adverse drug events (ADEs). Sensitivity analyses were performed to assess the robustness of results against uncertainties. RESULTS: A total of 852 interventions, based on 340 patients, were included. The analysis projected an annual total benefit of QAR 2,267,036 (USD 621,106) based on a negative cost-savings of QAR-175,139 (USD-47,983) and a positive cost avoidance of QAR741,898 (USD203,260) over the 3-month follow-up period. The uncertainty analysis demonstrated the robustness of outcomes, including a 100% probability of positive economic benefit. CONCLUSIONS: The clinical pharmacist intervention was associated with an increased cost of resource use, which was overtaken by the cost avoidance generated. The pharmacy intervention, therefore, is an overall economically beneficial practice in HGH, reducing ADEs with considerable consequential positive economic savings. Public Library of Science 2023-06-01 /pmc/articles/PMC10234553/ /pubmed/37262042 http://dx.doi.org/10.1371/journal.pone.0286419 Text en © 2023 Abushanab et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Abushanab, Dina
Atchan, Mounir
Elajez, Reem
Elshafei, Mohamed
Abdelbari, Ahmed
Al Hail, Moza
Abdulrouf, Palli Valapila
El-Kassem, Wessam
Ademi, Zanfina
Fadul, Abdalla
Abdalla, Elmustafa
Diab, Mohammad Issam
Al-Badriyeh, Daoud
Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar
title Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar
title_full Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar
title_fullStr Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar
title_full_unstemmed Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar
title_short Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar
title_sort economic impact of clinical pharmacist interventions in a general tertiary hospital in qatar
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234553/
https://www.ncbi.nlm.nih.gov/pubmed/37262042
http://dx.doi.org/10.1371/journal.pone.0286419
work_keys_str_mv AT abushanabdina economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT atchanmounir economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT elajezreem economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT elshafeimohamed economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT abdelbariahmed economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT alhailmoza economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT abdulroufpallivalapila economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT elkassemwessam economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT ademizanfina economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT fadulabdalla economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT abdallaelmustafa economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT diabmohammadissam economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar
AT albadriyehdaoud economicimpactofclinicalpharmacistinterventionsinageneraltertiaryhospitalinqatar